RAPAMYCIN PREPARATIONS FOR ORAL USING Russian patent published in 2002 - IPC

Abstract RU 2184541 C2

FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention relates to preparing a solid dosed form of rapamycin that includes a core and cover. This cover includes rapamycin, sucrose and one or more binding agents. Invention provides the development of a medicinal form providing the modified release of rapamycin. EFFECT: improved safety and facility of medicinal form. 16 cl, 1 tbl, 6 ex

Similar patents RU2184541C2

Title	Year	Author	Number
RAPAMYCIN SINGLE-UNIT SOLID DOSED FORM FOR PERORAL USING (VARIANTS), METHOD FOR ITS PREPARING	1998	Nagi Arvinder Singkh	RU2220714C2
VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE COMPOSITION, FILM COVER COMPOSITION, METHOD OF PROVIDING THERAPEUTICALLY ACTIVE VENLAFAXINE CONCENTRATION AND METHOD OF EXCLUDING ZERO AND PEAK CONCENTRATIONS OF MEDICINAL AGENT	1997	Sherman Debora M.	RU2176912C2
CONTROLLED STEROID RELEASING OUT OF SUGAR COVERINGS	1997	Barkom Redzhinal'D Dzhozef	RU2181586C2
SUGAR-BASE COMPOSITION FOR APPLYING ON TABLET, PRESSED TABLET	1996	Barkom Redzhinal'D Dzhozef	RU2152207C1
RAPAMYCIN ESTERS	1996	Khjuk-Koo Li Tianmin Zhu	RU2160739C2
C-22 STABILIZED DERIVATIVES OF RAPAMYCIN, METHOD OF IMMUNO- -SUPPRESSION INDUCING, METHOD OF TREATMENT AND PROPHYLAXIS OF TRANSPLANT REJECTION OR HOMOLOGOUS DISEASE, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERPROLIFERATIVE VASCULAR DISORDER	1994	Nelson Frehnsis Kristi	RU2152946C1
RAPAMYCIN DERIVATIVES, A PHARMACEUTICAL COMPOSITION AND A METHOD OF IMMUNODEPRESSION STIMULATING	1993	Venling Kao Magid A.Abou-Gkharbia Robert L.Vogel	RU2126409C1
RAPAMYCIN 42-OXIMES AND HYDROXYLAMINES, METHOD OF SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENT	1995	Amedeo Arturo Failli Gaj Alan Shikhser Oleg Igorevich Blejman	RU2172316C2
RAPAMYCIN HYDROXYESTERS, METHOD OF THEIR SYNTHESIS AND METHODS OF TREATMENT	1995	Dzheral'D Stenli Skotnitski Kristina Luiza Leon Gaj Alan Shizer	RU2134267C1
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS	1991	Majkl Sotirios Malamas[Gr]	RU2110518C1

RU 2 184 541 C2

Authors

Nadzhi Arvinder Singkh

Dates

2002-07-10—Published

1998-06-11—Filed